Advertisement

Topics

Merck Pharmaceuticals Company Profile

09:20 EST 14th December 2018 | BioPortfolio

The Merck Group is a global pharmaceutical and chemical company. In 2005, Merck Group sales totaled € 5,870 million. Adjusted for the disposal of VWR in the second quarter of 2004, this represents an increase of 9.9% over 2004. We increased our research and development spending, which has already been substantial for a number of years, by 19% to € 713 million. The operating result rose by a favorable 14% to € 883 million; return on sales (ROS) was 15.0% and return on capital employed (ROCE) reached a notable 20.5%.

Location

Harrier House,High Street
West Drayton
Middlesex
UB7 7QG
United Kingdom

Contact

Phone: 01895 452200
Fax: 01895 452274
Email: recruitment@merckpharma.co.uk


News Articles [1302 Associated News Articles listed on BioPortfolio]

Rexahn enters trial collaboration with Merck for breast cancer tx

Merck & Co. Inc. and Rexahn Pharmaceuticals Inc. penned an agreement to study the combination of Rexahn’s RX5902 (supinoxin) with Merck’s Keytruda (pembrolizumab) as a potential therapy for metast...

Rexahn Pharmaceuticals Announces Clinical Collaboration with Merck to Evaluate RX-5902 (Supinoxin) in combination with KEYTRUDA (pembrolizumab) for Triple Negative Breast Cancer

Rexahn Pharmaceuticals (NYSE:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced that it has entered into a clini...

Merck & InnoCore Pharmaceuticals enter cooperation agreement for drug delivery platform

Science and technology company, Merck, has entered into a cooperation agreement with Netherlands-based InnoCore Pharmaceuticals, for a new drug delivery platform that will aim to improve patient compl...

Rexahn Pharmaceuticals Partners with Merck to Evaluate RX-5902 in Combination with Keytruda in Triple Negative Breast Cancer

ROCKVILLE, Md. , Aug. 21, 2018 (GLOBE NEWSWIRE) — Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for th...

Merck Ventures: Success in funding early innovation

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core busi...

Merck KGaA Completes Consumer Health Sale

German pharmaceuticals, chemicals and laboratory products group Merck completed the sale of its Consumer Health business to US consumer products group Procter & Gamble (P&G) on Dec. 1. Belén ...

Merck & Co signs biosimilars deal for US veterans

Merck & Co has signed a deal with the US Department of Veterans Affairs (VA) for its inflammatory diseases biosimilar, Renflexis, so that veterans’ care can be improved. Merck, which is known a...

J&J collaborates with Merck to launch diabetes drug in China

Johnson & Johnson (J&J) subsidiary Xian Janssen Pharmaceuticals has signed a deal with Germany-based Merck to introduce Janssen’s diabetes drug...Read More... The post J&J collaborates ...

PubMed Articles [142 Associated PubMed Articles listed on BioPortfolio]

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective.

Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other f...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Merck vaccine heads Ebola countermeasures.

Effects of pharmaceuticals on microbial communities and activity of soil enzymes in mesocosm-scale constructed wetlands.

Cyperus alternifolius based mesocosm-scale constructed wetland was employed to remove pharmaceuticals. We investigated the microbial community composition using phosphor lipid fatty acids (PFLAs) anal...

Clinical Trials [311 Associated Clinical Trials listed on BioPortfolio]

A Bioequivalence Study of Montelukast From Asmakast 10mg Tabs (Sandoz, Egypt) & Singulair 10mg Tabs (Merck)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Montelukast fromAsmakast10 mg tablets (Man. by Minapharm Egypt for Novartis Pharm...

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

The purpose of this study is to evaluate the immunogenicity and safety of GSK Biologicals' trivalent MMR (Priorix®), comparing it to Merck's MMR vaccine (M-M-R®II), which is approved for...

Finasteride 5 mg Tablets Under Fasting Conditions

The objective of this study is to compare the relative bioavailability of finasteride 5 mg tablets (manufactured and distributed by TEVA Pharmaceuticals USA) with that of PROSCAR® 5 mg ta...

Study of EMD531444 in Subjects With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy

Darmstadt, Germany, June 17 2010 - Merck Serono, a division of Merck KGaA, and its U.S. affiliate, EMD Serono, Inc. today announced that they are resuming their Stimuvax® (BLP25 liposome ...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Companies [1467 Associated Companies listed on BioPortfolio]

Merck & Co

Here you will find an overview of our activities in the core businesses of pharmaceuticals and chemicals. We illustrate the structure of our company. We present the Executive Board of Merck KGaA. ...

Merck Animal Health

Today's Merck is a global healthcare leader working to help the world be well. Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global ...

The Merck Foundation

The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global health care leader, the Foundation is funded entirely by the company an...

Merck Foundation

The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global health care leader, the Foundation is funded entirely by the company an...

Merck Serono

Merck Serono is the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical company. Headquartered in Geneva, Switzerland, Merck Serono ...

More Information about "Merck Pharmaceuticals" on BioPortfolio

We have published hundreds of Merck Pharmaceuticals news stories on BioPortfolio along with dozens of Merck Pharmaceuticals Clinical Trials and PubMed Articles about Merck Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Merck Pharmaceuticals Companies in our database. You can also find out about relevant Merck Pharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record